Search results
Team links placental hormone spike to postpartum depression
Futurity· 2 hours agoFindings of a new study could help in early identification of mothers at risk for postpartum ...
Reality TV star shares battle with postpartum depression as a dad
Good Morning America via Yahoo News· 18 hours agoA reality TV star's decision to talk about his experience as a new dad is shining a light on a...
In 'The Unexpected,' Emily Oster tackles the emotional toll of difficult pregnancies
NPR· 3 hours agoThe Unexpected: Navigating Pregnancy During and After Complications, which came out this week,...
An AI blood test purports to diagnose postpartum depression
Washington Post· 3 days agoPostpartum depression is a leading cause of maternal death, but its diagnosis and treatment is spotty at best, negligent at worst. Now San Diego-based start-up ...
Can Esketamine Prevent Postpartum Depression?
Medscape· 6 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive via Yahoo Finance· 10 hours agoThe funding will help Reunion pay for a mid-stage study testing its most advanced medicine —...
15 volunteers for new mom — a community tackles postpartum depression in Calgary
CBC via Yahoo News· 3 days agoIn Calgary's northeast, a small non-profit has a unique way to fight postpartum depression and...
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 2 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum ...
“The Challenge”'s Leroy Garrett Talks Male Postpartum Depression: 'Hit Me Like a Ton of Bricks'...
People via Yahoo News· 2 days agoIn an exclusive clip shared with PEOPLE ahead of this week's episode of The Challenge: All Stars,...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 1 day agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...